AML, ADULT RECURRENT
Clinical trials for AML, ADULT RECURRENT explained in plain language.
Never miss a new study
Get alerted when new AML, ADULT RECURRENT trials appear
Sign up with your email to follow new studies for AML, ADULT RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy aims to stop blood cancers from coming back
Disease control Recruiting nowThis early-phase trial tests a new cell therapy called BSB-1001 in 38 adults with high-risk blood cancers (AML, ALL, or MDS) who have had a stem cell transplant. The therapy uses specially modified immune cells to target and kill cancer cells that may remain, with the goal of pre…
Matched conditions: AML, ADULT RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 26, 2026 11:04 UTC
-
New cell therapy aims to stop blood cancer relapse in tough-to-treat patients
Disease control Recruiting nowThis early-stage trial tests a new cell therapy called BSB-2002 in adults with a specific form of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goal is to check the safety of BSB-2002 and see if it can prevent the cance…
Matched conditions: AML, ADULT RECURRENT
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 26, 2026 10:35 UTC